Neuropharmacology

Neuropharmacology Photo

Dementia is a common clinical phenomenon; however, management of the coexisting illnesses remains incomplete. Neuropsychiatric turmoil is one of the clinical characteristics of Dementia. Traditionally, this turmoil has been managed with neuroleptics or benzodiazepines but accounts serious side effects. With the advancement in the neuropharmacology field, many new-fangled medications came into existence. Donepezil is a piper dine based reversible, non-competitive cholinesterase inhibitor and proved beneficial for the management of symptoms of Alzheimer’s disease covering dementia, a disease in which cholinergic pathways in the cerebral cortex and basal forebrain are well known to be compromised.


  • Dementia & Pharmacotherapy
  • Memory Drugs
  • Cholinesterase inhibitors
  • Partial NMDA Antagonists
  • Memantine
  • Vitamin E for cognitive changes
  • Immunotherapies
  • Antioxidants
  • Pharmacotherapeutics
  • Neurochemical Pharmacology
  • Recent Trend in Neuropharmacology for Dementia
  • Dementia & Pharmacotherapy
  • Memory Drugs
  • Cholinesterase inhibitors
  • Partial NMDA Antagonists
  • Memantine
  • Vitamin E for cognitive changes
  • Immunotherapies
  • Antioxidants
  • Pharmacotherapeutics
  • Neurochemical Pharmacology
  • Recent Trend in Neuropharmacology for Dementia

Are you interested in

Mail us at

Drop us a mail program enquiry
dementiacare@alliedconference.com
Sponser/Exhibiting/advertising
dementiacare@alliedconference.com
General queries
dementiacare@alliedconference.com
Copyright © 2017-2018 Allied Academies, All Rights Reserved.